Quoin Pharmaceuticals, Ltd. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| LANGER DENNIS | — | Purchase | 15,152 | $8.49 | $128,640 | 15,153 | Oct 14, 2025 |
| Carter Denise P. | Chief Operating Officer | Purchase | 555,556 | $0.45 | $250,000 | 602,648 | Dec 23, 2024 |
| Myers Michael | Chief Executive Officer | Purchase | 555,556 | $0.45 | $250,000 | 602,808 | Dec 23, 2024 |
| Dunn Gordon | Chief Financial Officer | Purchase | 122,221 | $0.45 | $54,999 | 151,077 | Dec 23, 2024 |
| Culverwell Anthony James | — | Purchase | 100,000 | $0.45 | $45,000 | 100,317 | Dec 23, 2024 |
| Dunn Gordon | Chief Financial Officer | Purchase | 10,000 | $0.71 | $7,100 | 28,856 | Sep 10, 2024 |
| Myers Michael | Chief Executive Officer | Purchase | 8,200 | $0.75 | $6,150 | 23,680 | Sep 4, 2024 |
| Carter Denise P. | Chief Operating Officer | Purchase | 22,988 | $0.80 | $18,390 | 47,092 | Sep 3, 2024 |
| LANGER DENNIS | — | Sale | 297 | $0.73 | $217 | 53 | Jun 7, 2024 |